Please use this identifier to cite or link to this item:
Type: Artigo
Title: Management of chronic myeloid leukemia during pregnancy: a retrospective analysis at a single center
Author: Moura, A.C.D.
Delamain, M.T.
Duarte, G.B.O.
Lorand-Metze, I.
Souza, C.A.D.
Barbosa Pagnano, K.B.
Abstract: We analyzed the management and outcomes of pregnancies of patients with chronic myeloid leukemia at a single center over fifteen years. Among the 203 CML female patients, there were ten pregnancies in seven women, all of them not planned. In three cases, the chronic myeloid leukemia diagnosis was made during pregnancy. Five patients received tyrosine kinase inhibitors in the first weeks of pregnancy and the drug was interrupted until delivery. One patient lost complete cytogenetic response, and two patients lost the hematological response. A patient with a stable major molecular response had two successful pregnancies without loss of response. There were four premature births. There were no maternal adverse events, fetal malformation or death. All patients received Interferon-alpha during gestation, and two received hydroxyurea for a short period. Leukapheresis was performed in two patients for hyperleukocytosis control. One patient with sickle cell disease died from disease progression six months after delivery. Conclusions: The tyrosine kinase inhibitors ministration should be interrupted during pregnancy. Patients should be advised to achieve a stable and deep molecular response if they plan to conceive, to avoid the risk of disease progression
Subject: Leucemia mielóide crônica
Country: Brasil
Editor: Elsevier
Rights: Fechado
Identifier DOI: 10.1016/j.htct.2018.10.001
Date Issue: 2019
Appears in Collections:FCM - Artigos e Outros Documentos
HEMO - Artigos e Outros Documentos

Files in This Item:
File Description SizeFormat 
2-s2.0-85063135218.pdf534.45 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.